AxonDx Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

AxonDx General Information


Developer of a circulating tumor cells detection device designed to scan all nucleated cells in a blood sample. The company's device scans un-enriched blood samples in minutes, finds all classes of circulating tumor cells shed by solid tumors and offers morphological and outsourced molecular characterization of positive cells, enabling cancer users to self diagnose early stage cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Primary Office
  • 379 Reas Ford Road
  • Suite 1
  • Earlysville, VA 22936
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AxonDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-May-2020 Completed Generating Revenue
To view AxonDx’s complete valuation and funding history, request access »

AxonDx Executive Team (2)

Name Title Board Seat Contact Info
Phil Couch Ph.D Chief Technology Officer
Kent Murphy Ph.D President & Chief Executive Officer
To view AxonDx’s complete executive team members history, request access »

AxonDx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
To view AxonDx’s complete investors history, request access »